Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | 1.59% | 182.51 | 0.7% | $1411.48m | |
| MRK | Merck & Co., Inc. | 1.39% | 93.28 | 0.7% | $1241.52m | |
| PFE | Pfizer Inc. | 3.21% | 51.70 | 0.9% | $1234.19m | |
| BMY | Bristol-Myers Squibb Co. | 1.67% | 78.99 | 1.0% | $1137.41m | |
| LLY | Eli Lilly & Co. | 4.15% | 325.69 | 1.1% | $1136.04m | |
| ABBV | AbbVie, Inc. | 2.07% | 152.55 | 1.9% | $1019.26m | |
| AZN | AstraZeneca Plc | 3.80% | 66.90 | 1.0% | $452.09m | |
| SGEN | Seagen Inc. | 3.06% | 179.33 | 5.7% | $326.01m | |
| GSK | GSK Plc | 2.20% | 43.69 | 0.2% | $297.44m | |
| TPTX | Turning Point Therapeutics, Inc. | 0.03% | 75.17 | 0.0% | $291.93m | |
| SIGA | SIGA Technologies, Inc. | -0.46% | 13.04 | 0.0% | $219.68m | |
| MRTX | Mirati Therapeutics, Inc. | 3.45% | 68.16 | 1.6% | $199.41m | |
| HZNP | Horizon Therapeutics Plc | 2.68% | 85.13 | 5.4% | $182.59m | |
| NVS | Novartis AG | 3.62% | 84.82 | 0.2% | $167.75m | |
| BHVN | Biohaven Pharmaceutical Holding Co. Ltd. | -0.14% | 144.00 | 0.0% | $147.86m |
Company Profile
Kiora Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes KIO-301, which is designed to restore vision in patients with inherited and age-related degenerative retinal disease, KIO-101 for patients with Ocular Presentation of Rheumatoid Arthritis, KIO-201 for patients undergoing PRK surgery for corneal wound repair after refractive surgery, and KIO-102. The company was founded in 1998 and is headquartered in Salt Lake City, UT.